rotenone has been researched along with Abnormal Movements in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Azar, YO; Badawi, GA; Ibrahim, SM; Zaki, HF | 1 |
Arias-Carrión, O; El-Gamal, M; Ellaithy, A; Helmy, B; Mohamed, M; Salama, M; Sheashaa, H; Sobh, M; Tantawy, D | 1 |
Betarbet, R; Garcia-Osuna, M; Greenamyre, JT; MacKenzie, G; Panov, AV; Sherer, TB | 1 |
3 other study(ies) available for rotenone and Abnormal Movements
Article | Year |
---|---|
Agmatine-mediated inhibition of NMDA receptor expression and amelioration of dyskinesia via activation of Nrf2 and suppression of HMGB1/RAGE/TLR4/MYD88/NF-κB signaling cascade in rotenone lesioned rats.
Topics: Agmatine; Animals; Antioxidants; Dyskinesias; HMGB1 Protein; Levodopa; Myeloid Differentiation Factor 88; NF-E2-Related Factor 2; NF-kappa B; Oxidopamine; Parkinson Disease; Rats; Receptors, N-Methyl-D-Aspartate; Rotenone; Signal Transduction; Toll-Like Receptor 4 | 2022 |
Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Catalepsy; Colchicine; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Dyskinesias; Injections, Intraperitoneal; Locomotion; Nerve Tissue Proteins; Neuroprotective Agents; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotenone; Substantia Nigra; Tremor; Tubulin Modulators; Tyrosine 3-Monooxygenase | 2012 |
Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
Topics: Animals; Dopamine; Dyskinesias; Electron Transport Complex I; Environmental Exposure; Lewy Bodies; Male; NADH, NADPH Oxidoreductases; Neostriatum; Nerve Degeneration; Neural Pathways; Neurons; Parkinson Disease; Parkinson Disease, Secondary; Presynaptic Terminals; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Rotenone; Substantia Nigra | 2000 |